Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test or the detection of microalbuminuria

Diabetes Care

Volumn 20, Issue 11, 1997, Pages 1642-1646

  Mogensen, Carl E ^a   Viberti, Gian C ^b   Peheim, Edgar ^c   Kutter, Dolphe ^d   Hasslacher, Christoph ^e   Hofmann, Walter ^f   Renner, Rolf ^f   Bojestig, Mats ^g   Poulsen, P Logstrup ^a   Scott, Graham ^b   Thoma, John ^d   Kuefer, Juergen ^e   Nilsson, B ^g   Gambke, Brigitte ^h   Mueller, Peter ^h   Steinbiss, Joachim ^h   Willamowski, Klaus Dieter ^h  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b GUY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^e StJosefs Krankenhaus Heidelberg   (Germany)

^f KLINIKUM BOGENHAUSEN   (Germany)

^g Hoeglandssjukhuset ^*  (Sweden)

^h F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTETRACYCLINE;

ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; FEMALE; HEMATURIA; HUMAN; IMMUNOLOGICAL PROCEDURES; LEUKOCYTURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTICENTER STUDY; SCORING SYSTEM; TEST STRIP; URINALYSIS;

EID: 0030833971     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.11.1642     Document Type: Article

References (15)

1. Borch Johnsen K, Wenzel H, Viberti GC, Mogensen CE: Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ 306:1722-1723, 1993
2. Whiteside Cl: Detection of progressive diabetic nephropathy: role of microalbuminuria determination. Clin Biochem 26:311-313, 1993
3. Mogensen CE: Proceedings of a meeting on epidemiology of microalbuminuria, November 13, 1993, Mortefontaine, France. J Diabet Complications 8:133-192, 1993
4. The Diabetes Control and Complication Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, Steffes MW, Striker GE, Viberti GC: Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346:1080-1084, 1995
6. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 297:1092-1095, 1988
7. The Microalbuminuria Captopril Study group: Captopril reduces the risk of nephropathy in insulin-dependent diabetic patients with microalbuminuria. Diabetologia 39:587-593, 1996.
8. Mathiesen ER, Hommel E, Giese J, Parving HH: Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 303:81-87, 1991
9. Poulsen PL: Office tests for microalbuminuria. In The Kidney and Hypertension in Diabetes Mellitus. Mogensen CE, Ed. Boston, MA, Kluwer, 1994, p. 95-102
10. Le Floch JP, Charles MA, Philippon C, Perlemuter L: Cost-effectiveness of screening for microalbuminuria using immunochemical dipstick tests or laboratory assays in diabetic patients. Diabet Med 11:349-356, 1994
11. ®. Clin Biochem 26:283-287, 1993
12. Poulsen PL, Mogensen CE: Evaluation of a new semiquantitative stix for microalbuminuria. Diabetes Care 18:732-733, 1995
13. Viberti GC, Mogensen CE, Passa P, Bilous R, Mangili R: St Vincent Declaration, 1994: Guidelines for the prevention of diabetic renal failure. In The Kidney and Hypertension in Diabetes Mellitus. Mogensen CE, Ed. Boston, MA, Kluwer, 1994, p. 515-527
14. Biesenbach G, Kaiser W, Grafinger P, Stuby U, Janko O, Zazgornik J: Mikroalbuminurie bei essentieller Hypertonie und normaler Nierenfunktion. Wiener Medizinische Wochenschr 142:23-26, 1992
15. Fliser D, Arnold U, Ritz E: Prävalenz der Mikroalbuminurie bei Patienten mit primärer Hypertonie. Nieren-und Hochdruckkrankheiten 21:660-661, 1992